Search

for
Search:

Research

5 / 1000+ results

research Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis

August 2025 in “SSP Modern Pharmacy and Medicine”

This analytical review of alopecia treatments in the US found that drugs like minoxidil and finasteride are most affordable and effective, while newer JAK inhibitors show significant clinical results but are cost-prohibitive; the study stresses individualizing treatment based on financial capability and alopecia type.

research Repurposing of Linagliptin Similar FDA Approved Drugs as Antidiabetic Agents

May 2021 in “Letters in Applied NanoBioScience”

This study used computational methods to identify pranlukast and mirabegron as promising candidates for repurposing against diabetes due to their good binding interactions with the DPP-IV target.

research Development of validated methods for the simultaneous quantification of Finasteride and Tadalafil in newly launched FDA-approved therapeutic combination: greenness assessment using AGP, analytical eco-scale, and GAPI tools

January 2023 in “RSC Advances”

This study found that two eco-friendly analytical methods for quantifying Finasteride and Tadalafil in a new dosage form were effective, green, and suitable for quality control.

research 73143 Stem Cell Therapies for Androgenetic Alopecia: A Systematic Review and Single-Arm Meta-analysis

July 2026 in “Journal of the American Academy of Dermatology”

Stem cell therapies might help with hair loss, but more research is needed to confirm their safety and effectiveness.

research Not Its Crowning Glory: Obstacles for FDA in Regulating Ingested Dietary Supplements Purporting to Prevent Hair Loss

January 2005 in “Digital Access to Scholarship at Harvard (DASH) (Harvard University)”

This article examines how the Dietary Supplement Health and Education Act of 1994 allows ineffective herbal remedies for hair loss to remain on the market, potentially misleading consumers, and suggests possible solutions.

View more "fda approved solutions" in research →

Community Join

5 / 769 results

community Why are there no FDA approved NSAA's yet?

in Research/Science 2 years ago

The conversation discusses why there are no FDA-approved NSAAs like RU58841 on the market, despite their potential superiority to 5AR inhibitors like finasteride. It explores the effectiveness of treatments like Minoxidil, finasteride, and RU58841 for hair loss.

community I had claude create a protocol only using fda approved drugs.

4 upvotes 8 months ago

A new hair loss protocol using FDA-approved topical treatments targets eight pathways, potentially improving results by 60-75% compared to the standard 40-50% from oral minoxidil and finasteride. The protocol includes minoxidil, finasteride, tacrolimus, cetirizine, bimatoprost, lithium gluconate, losartan, melatonin, NAC, caffeine, and tretinoin, with a monthly cost of $35-50 in Mexico and $80-150 in the US.

community How much will GT20029 cost if it becomes FDA approved?

6 upvotes 2 years ago

The conversation is about the potential cost of GT20029 if FDA approved, with estimates around $150/month. Comparisons are made between GT20029, finasteride, and their mechanisms and side effects.

community Which 2026 hair‑loss treatments have the strongest evidence so far? (minoxidil/finasteride vs. clascoterone, PP405, Re:You’s NV‑623/624, AMP‑303, RU58841)

44 upvotes 3 months ago

Minoxidil and finasteride are the only FDA-approved treatments for androgenetic alopecia, while newer treatments like clascoterone, PP405, NV-623/624, AMP-303, and RU58841 are still experimental with varying levels of evidence. Clascoterone shows the most promise due to strong human data, while AMP-303 has notable early human trial results; RU58841 lacks human data and remains experimental.

community With studies showing that 0.2mg Finasteride is almost as effective as 5mg at reducing DHT, why is every doctor prescribing 1mg?

252 upvotes 10 months ago

Finasteride is prescribed at 1mg because it is FDA-approved and proven effective, despite evidence that 0.2mg may similarly reduce DHT. The 1mg dose is more effective for hair growth, and lower doses are less available.

View more "fda approved solutions" in community →

Learn

7 / 21 results

learn Clascoterone

Topical androgen-receptor blocker, approved as an acne cream

learn Bimatoprost

Prostaglandin eye drop used for glaucoma and eyelash growth

Can a lash-growth serum like bimatoprost actually work for your scalp? Bimatoprost (Latisse) is FDA-approved only for eyelashes, not the scalp. In the larger of two Allergan phase 2 scalp trials, every bimatoprost formulation gave smaller hair-count gains than minoxidil 5%; the results were posted to ClinicalTrials.gov but never published in a journal, and scalp use remains off-label and experimental.
How does bimatoprost compare to minoxidil for hair regrowth? Minoxidil is FDA-approved for scalp hair loss and backed by decades of large trials; bimatoprost is approved only for eyelashes, and the published scalp evidence is limited to small short studies, so on the scalp it is off-label and experimental.

learn Scalp Micropigmentation

scalp tattoos to mimic the appearance of light stubble

learn Cetirizine

Antihistamine allergy medicine

learn Finasteride

Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

learn Exosomes

Do exosome-based treatments require medical supervision or can they be done at home? No exosome product is FDA-approved, for home or clinic use, and FDA has reported serious adverse events in patients who received unapproved exosome products. Home kits add risks of contamination, infection and unknown contents.

learn Baricitinib

Baricitinib: Can I use it even if I don’t have a medical diagnosis but I have patchy hair loss? Baricitinib is approved only for adults with a diagnosis of severe alopecia areata and carries an FDA boxed warning. Patchy hair loss has many causes, so doctors confirm the diagnosis before prescribing it.
Can Baricitinib work if my hair loss is from stress or anxiety? Baricitinib is approved for severe alopecia areata in adults, an autoimmune condition. It has not been shown to work for stress-related shedding (telogen effluvium) and carries an FDA boxed warning.

View more "fda approved solutions" in learn →

Clinics

6 / 436 results

All 436 clinic results →

Experts

— no results

Try a deeper search in experts →